Shingrix, oral semaglutide, biosimilars, and more In this edition explore how Truveta Research sheds light on adult vaccination trends and persistent access gaps, real-world dosing trends for oral semaglutide, biosimilar switching patterns in clinical practice, and the continued rise of hormone replacement therapy
Major insurers like Blue Cross Blue Shield and United Healthcare may cover Wegovy, but only if its prescribed for an approved use, such as chronic weight management or reducing cardiovascular risk in eligible individuals
Clinical rigour
Monitor for hypoglycemia symptoms, particularly if taking concurrent insulin or sulfonylureas
Holistic approaches to knee OA go beyond symptoms management, with the goal of improving mobility, stability and function
Psychiatrists and PMHNPs who position themselves now as experts in integrated mental health and metabolic care will have a competitive advantage